The Pfizer/BioNTech vaccine may be rolled out in mere weeks.
L’expertise universitaire, l’exigence journalistique
Articles sur COVID-19
Affichage de 4061 à 4080 de 7938 articles
The government should look beyond traditional socioeconomic arguments for why some patients are at greater risk.
African countries have proven that they have the skills and expertise to provide local solutions to this global pandemic. They need to build on this success together to keep the pandemic at bay.
African countries need multi-sectoral approaches to tackle food insecurity.
The fact that there’s a growing number of child vendors means government interventions for vulnerable children aren’t reaching everyone in need.
Lockdown increased the appetite for on-demand viewing.
Shielding people based on their individual risk profile has been proposed by some experts.
Coronavirus made these two problems worse during the first wave. We need to be better prepared for the second.
US president-elect Joe Biden is taking expert advice on how to tackle the US coronavirus crisis. But is that enough?
Side agreements signed by some wealthy nations threaten to undercut global efforts to ensure a fairly equitable worldwide vaccination effort.
Act now. Anything ordered from late November may not arrive until 2021.
The need for much-improved internet connectivity exists across Canada. Will the Ontario government’s recent announcement of $1 billion and the federal government’s announcement of the Universal Broadband Fund of $1.75 billion for improved broadband be enough to make a difference?
In science, vaccine efficacy and effectiveness mean something different.
The Pfizer/BioNTech vaccine needs to be stored at -80⁰C.
Interim analysis of trial data isn’t unusual – but leaves us with many things we still need to find out.
Digital contact tracing apps can successfully contribute to the management of viral outbreaks. These apps can even be designed to protect privacy rights and to work across borders.
Among the health conditions that might have faced a setback is leishmaniasis, a parasitic disease associated with poverty. It can cause devastating lifestyle changes, disability, and even death.
COVID-19 and holiday family gatherings are not a good pair. But taking the right precautions before, during and after the family gets together can greatly reduce coronavirus risk this holiday season.
With COVID-19 cases soaring across the US and worldwide, the need for a vaccine could not be greater. Here’s where we stand on vaccine development, including positive results from Pfizer’s trial.
Early analysis suggests this vaccine has an efficacy of over 90%. So if you took ten people who were going to get sick from COVID-19 and vaccinated them, only one would get sick.
Les contributeurs les plus fréquents
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Senior Research Fellow in Global Health, University of Southampton
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Medicine, University of East Anglia
-
Associate professor, UNSW Sydney
-
Professor of Medicine, University of Virginia
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Public Health, University of Sheffield
